Skip to main content
SpringerLink
Log in

GnRH-Analoga in der Endometriosetherapie

GnRH analogues in treatment of endometriosis

  • Arzneimitteiltherapie
  • Published:
Gynäkologische Endokrinologie Aims and scope

Zusammenfassung

GnRH-Analoga sind gegenwärtig die effektivsten Medikamente zur Regression der Endometrioseherde und zur Reduktion der endometriosebedingten Beschwerden. Kombiniert mit einer niedrig dosierten so genannten Add-back-Medikation ist die Behandlung effektiv und nebenwirkungsarm. Die verschiedenen GnRH-Analoga, die in Deutschland auf dem Markt sind, unterscheiden sich nicht hinsichtlich ihrer Wirksamkeit, jedoch haben Depotpräparationen die beste Compliance. Der gezielte Einsatz der Medikation postoperativ oder anstatt einer Operation, zur Rezidivprophylaxe oder zur Rezidivtherapie hängt von der individuellen Situation der Patientin und von Lokalisation, Aktivität, Wachstumstyp und Schweregrad der Endometriose ab.

Abstract

GnRH analogues are currently the most effective medications used to achieve regression of islands of endometriosis and attenuate endometriosis-related symptoms. In combination with low-dose add-back medication they are effective and their side effects are few and tolerable. The different types of GnRH analogues available in Germany do not differ in effectiveness, but patient compliance is best with depot preparations. Whether GnRH analogues are used after or instead of surgery, to prevent recurrences or to treat recurrences depends on the individual situation of the patient and on the proliferative activity, localisation, type and stage of the endometriosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Abbott JA, Hawe J, Clayton RD, Garry R (2003) The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2–5 year follow up. Hum Reprod 18: 1222–1227

    Article  Google Scholar 

  2. Barhart K, Dunsmoor-Su R, Coutifaris C (2002) Effect of endometriosis on in vitro fertilisation. Fertil Steril 77: 1148–1155

    Article  PubMed  Google Scholar 

  3. Bianchi S, Busacca M, Agnoli B (1999) Effects of 3 months therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomised study. Hum Reprod 14: 1335–1337

    Article  PubMed  Google Scholar 

  4. Busacca M, Somigliana E, Bianchi S (2001) Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III–IV: a randomised controlled trial. Hum Reprod 16: 2399–2402

    PubMed  Google Scholar 

  5. Freundl G, Gödtke K, Gnoth C (1998) Steroidal ‚add-back‘ therapy in patients treated with GnRH agonists. Gynaecol Obstet Invest 45: 22–30

    Article  Google Scholar 

  6. Hemmings R (1998) Combined treatment of endometriosis. GnRH agonists and laparoscopic surgery. J Reprod Med 43: 316–320

    PubMed  Google Scholar 

  7. Hippach M, Hinrichs I, Schweppe KW (2003) Möglichkeiten der Langzeittherapie bei rezidivierender Endometriose. Zentralbl Gynakol 125: 303

    Google Scholar 

  8. Hornstein MD, Yuzpe AA, Burry KA (1995) Prospective randomised double-blind trial of 3 versus 6 months of narfarelin therapy for endometriosis associated pelvic pain. Fertil Steril 63: 955–962

    PubMed  Google Scholar 

  9. Hornstein MD, Hemmings R, Yuzpe AA (1997) Use of narfarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril 68: 860–864

    Article  PubMed  Google Scholar 

  10. Hughes E, Fedorkow D, Collins J (2004) Ovulation suppression for endometriosis (Cochrane Review). The Cochrane Library, Issue 3. John Wiley & Sons Ltd, Chichester

  11. Kampe D, Sahl AC, Schweppe K-W (2003) Prä- und postoperative Endometriosetherapie mit GnRH-Agonisten in Depotform: drei- versus sechsmonatige Behandlungsdauer. Zentralbl Gynakol 125: 304

    Google Scholar 

  12. Kennedy S, Bergqvist A, Chapron C (2005) ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20: 2698–2704

    Article  PubMed  Google Scholar 

  13. Kiesel L, Schweppe K-W, Sillem M (1996) Should add-back therapy for endometriosis be deferred for optimal results? Br J Obstet Gynaecol 103: 15–17

    PubMed  Google Scholar 

  14. Lee PA, Houk CP (2005) Outcome among adult females after treatment of central precocious puberty (CPP) with GnRH analogue (GnRH-A). 8th International Symposium on GnRH-Analogues, Geneva, Abstract 68

  15. Lunenfeld B, Insler V (eds) (1996) GnRH-analogues: the state of the art. Parthenon, Lancaster New York

  16. Malinak LR (1993) Surgical treatment and adjunct therapy of endometriosis. Int J Gynaecol Obstet 40: 43–47

    Google Scholar 

  17. Marcoux S, Maheux R, Berube S (1997) Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med 337: 217–222

    Article  PubMed  Google Scholar 

  18. Meldrun DR, Chang RJ, Lu J (1982) Medical oophorectomy using a long-acting GnRH agonist: a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 54: 1081–1083

    PubMed  Google Scholar 

  19. Mori H, Taketani Y, Uemura T (1999) Rates of endometriosis recurrence and pregnancy 1 year after treatment with intranasal buserelin acetate (Suprecur) (a prospective study). J Obstet Gynaecol Res 25: 153–164

    PubMed  Google Scholar 

  20. Muzii L, Marana R, Caruana P (2000) Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomised trial. Am J Obstet Gynecol 183: 588–592

    Article  PubMed  Google Scholar 

  21. Parazzini F (12999) Ablation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomised trial. Gruppo Italiano per lo Studio dell‘ Endometriosi. Hum Reprod 14: 1332–1334

    Google Scholar 

  22. Prentice A, Deary AJ, Bland E (2003) Progestagens and anti-progestagens for pain associated with endometriosis. The Cochrane Library, Issue 3. John Wiley & Sons Ltd, Chichester

  23. Radwanska E (1999) The effect of GnRH agonist suppression on the outcome of infertility treatment in women with endometriosis. 5th International Symposium on GnRH Analogues, Geneva, Abstract 86

  24. Regidor PA (2005) GnRH-agonists and endometriosis: comparison of nasal spray and depot formulations. 8th International Symposium on GnRH-Analogues, Geneva, Abstract 60

  25. Regidor PA, Regidor M, Ruwe B (2001) Prospective randomised study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecol Endocrinol 15: 202–209

    PubMed  Google Scholar 

  26. Regidor PA, Wagner I, Ruwe M (2002) Morphometric analyses of endometriotic tissues to determine their grade of activity. Gynecol Endocrinol 16: 235–243

    PubMed  Google Scholar 

  27. Rickes D, Nickel I, Kropf S (2002) Increased pregnancy rates after ultra long postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 78: 757–762

    Article  PubMed  Google Scholar 

  28. Rickes D, Weiß M, Nickel I (2003) Ovarielle Ansprechbarkeit auf rekombinante Gonadotropine nach ultralanger „Dornregulation“ mit GnRH-Analoga. Zentralbl Gynakol 125: 306

    Google Scholar 

  29. Ruwe M, Donhuijsen K, Regidor PA (1998) Endometriose: klinische, histologische und morphometrische Befunde vor und nach Gn-RH-Agonisten-Therapie. Zentralbl Gynakol 120: 391–398

    PubMed  Google Scholar 

  30. Schultze-Mosgau A, Driesinger G, Altgassen C et al. (2005) New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists. Expert Opin Investig Drugs 14: 1085–1097

    Article  PubMed  Google Scholar 

  31. Schweppe KW (1984) Klinik und Morphologie der Endometriose. Schattauer, Stuttgart New York

  32. Schweppe KW (1999) Aktive – inaktive Endometriose – eine prognose- und therapierelevante Differentialdiagnose. Zentralbl Gynakol 121: 330–335

    PubMed  Google Scholar 

  33. Schweppe KW (2005) The use of GnRH analogues before and after surgery for endometriosis – clinical problems and experiences. 8th International Symposium on GnRH-Analogues, Geneva, Abstract 37

  34. Schweppe KW, Ring D (2002) Peritoneal defects and the development of endometriosis in relation to the timing of endoscopic surgery during the menstrual cycle. Fertil Steril 78: 763–766

    Article  PubMed  Google Scholar 

  35. Shaw RW (1992) The role of GnRH analogues in the treatment of endometriosis. Br J Obstet Gynaecol 99: 9–12

    PubMed  Google Scholar 

  36. Surrey ES, Hornstein MD (2002) Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long term follow up. Obstet Gynecol 99: 709–719

    Article  PubMed  Google Scholar 

  37. Surrey ES, Silverberg KM, Surrey MW (2002) Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilisation – embryo transfer in patients with endometriosis. Fertil Steril 78: 699–704

    Article  PubMed  Google Scholar 

  38. Sutton CJG, Ewen SP, Whitelaw N (1994) Prospective, randomised, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild and moderate endometriosis. Fertil Steril 62: 696–700

    PubMed  Google Scholar 

  39. Templeton A, Morris JK, Parslow W (1996) Factors that affect outcome of in-vitro fertilisation treatment. Lancet 348: 1402–1406

    Article  PubMed  Google Scholar 

  40. Tinneberg HR, Manolopoulos K (2005) Reproductive medicine: comparison of depot formulations of GnRH-agonists, daily injections and nasal spray. 8th International Symposium on GnRH-Analogues, Geneva, Abstract 59

    Google Scholar 

  41. Uemura T, Shirasu K, Katagiri N (1999) Low-dose GnRH agonist therapy for the management of endometriosis. J Obstet Gynaecol Res 25: 295–301

    PubMed  Google Scholar 

  42. Uemura T, Yoshikata H, Ishikawa M (1999) Effects of pre-treatment with GnRH-agonists on bone mineral density in patients with endometriosis. 5th International Symposium on GnRH-Analogues, Geneva, Abstract 45

  43. Vercellini P, Crosignani PG, Fadini R (1999) A gonadotropin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol 6: 672–677

    Google Scholar 

  44. Waller KG, Shaw RW (1993) Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 59: 511–515

    PubMed  Google Scholar 

  45. Zupi E, Marconi D, Sbracia M (2004) Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril 82: 1303–1308

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frauenklinik, Ammerland Klinik GmbH, Akademisches Lehrkrankenhaus, Universität Göttingen, Lange Straße 38, 26655 , Westerstede

    K.-W. Schweppe

Authors
  1. K.-W. Schweppe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K.-W. Schweppe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schweppe, KW. GnRH-Analoga in der Endometriosetherapie. Gynäkologische Endokrinologie 4, 113–119 (2006). https://doi.org/10.1007/s10304-006-0145-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-006-0145-x

Schlüsselwörter

Keywords

Search

Navigation